Los Angeles Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $839K | Buy |
|
|||||
|
2025
Q2 | $282K | Sell |
|
|||||
|
2025
Q1 | $267K | Sell |
|
|||||
|
2024
Q4 | $703K | Sell |
|
|||||
|
2024
Q3 | $710K | Sell |
|
|||||
|
2024
Q2 | $608K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $282K | Sell |
|
|||||
|
2021
Q1 | $343K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $221K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $423K | Sell |
|
|||||
|
2019
Q3 | $1.05M | Buy |
|
|||||
|
2019
Q2 | $1.12M | Sell |
|
|||||
|
2019
Q1 | $1.7M | Buy |
|
|||||
|
2018
Q4 | $1.01M | Buy |
|
|||||
|
2018
Q3 | $1.32M | Buy |
|
|||||
|
2018
Q2 | $601K | Hold |
|
|||||
|
2018
Q1 | $479K | Buy |
|
|||||
|
2017
Q4 | $394K | Buy |
|
|||||
|
2017
Q3 | $230K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $207K | Buy |
|